These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prions and prion diseases. Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898 [No Abstract] [Full Text] [Related]
3. Human prion diseases: molecular and clinical aspects. Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251 [TBL] [Abstract][Full Text] [Related]
4. Biomedicine. A view from the top--prion diseases from 10,000 feet. Priola SA; Chesebro B; Caughey B Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843 [No Abstract] [Full Text] [Related]
5. Neurotoxic species in prion disease: a role for PrP isoforms? Harrison CF; Barnham KJ; Hill AF J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867 [TBL] [Abstract][Full Text] [Related]
6. Prions: proof of proteinaceous nature but problems with population polymorphisms. Griffiths PD Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195 [No Abstract] [Full Text] [Related]
7. [Prions]. Wieland S; von Weizsäcker F; Blum HE Dtsch Med Wochenschr; 1996 Jul; 121(30):949-52. PubMed ID: 8765704 [No Abstract] [Full Text] [Related]
8. Folding and misfolding of the prion protein in the secretory pathway. Tatzelt J; Winklhofer KF Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918 [TBL] [Abstract][Full Text] [Related]
9. Prion diseases. Yielding under the strain. Weissmann C Nature; 1995 Jun; 375(6533):628-9. PubMed ID: 7791890 [No Abstract] [Full Text] [Related]
10. Photo-induced crosslinking of prion protein oligomers and prions. Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960 [TBL] [Abstract][Full Text] [Related]
11. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations. Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523 [TBL] [Abstract][Full Text] [Related]
12. [Intermediate conformer of prion and dynamics based drug design (DBDD)]. Kazuo K Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1110-2. PubMed ID: 15168541 [No Abstract] [Full Text] [Related]
13. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein. Sakudo A; Ikuta K Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734 [TBL] [Abstract][Full Text] [Related]
14. Prion proteins: a biological role beyond prion diseases. Hu W; Rosenberg RN; Stüve O Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791 [TBL] [Abstract][Full Text] [Related]
15. Human prion disease and human prion protein disease. Kitamoto T; Tateishi J Curr Top Microbiol Immunol; 1996; 207():27-34. PubMed ID: 8575204 [No Abstract] [Full Text] [Related]
16. Prion diseases: from transmission experiments to structural biology--still searching for the cause. Liberski PP; Brown P Folia Neuropathol; 2004; 42 Suppl A():15-32. PubMed ID: 15449457 [No Abstract] [Full Text] [Related]
17. The state of the prion. Weissmann C Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743 [TBL] [Abstract][Full Text] [Related]
18. Games played by rogue proteins in prion disorders and Alzheimer's disease. Aguzzi A; Haass C Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165 [TBL] [Abstract][Full Text] [Related]
19. Shrinking prions: new folds to old questions. Aguzzi A; Brandner S Nat Med; 1999 May; 5(5):486-7. PubMed ID: 10229220 [No Abstract] [Full Text] [Related]
20. On safari with PrP: prion diseases of animals. Westaway D; Carlson GA; Prusiner SB Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]